Portal hypertension (portalhypertension) is a series of clinical manifestations caused by elevated pressure in the portal venous system, mainly manifested by: esophagogastric fundic varices with upper gastrointestinal bleeding, splenomegaly and hypersplenism, and intractable ascites. The rupture of esophagogastric fundic varices due to portal hypertension accounts for 5% to 14% of gastrointestinal bleeding; traditional pharmacological hemostasis, endoscopic ligature and glue hemostasis under direct vision, three-chamber diathermy tube compression hemostasis, and interventional embolization hemostasis can effectively control bleeding in the short term because they cannot change the hemodynamics, and the recurrence rate is extremely high; while surgical bypass surgery is traumatic and risky, and difficult for patients to accept; when pharmacological treatment When both pharmacological and endoscopic conventional treatments fail to control acute bleeding, the mortality rate of patients can reach 80%. Many of these patients are unsuitable and less likely to undergo surgery due to poor general condition, critical illness and severe liver disease. Based on previous experience, these patients also have a high mortality rate (31%-77%) when undergoing emergency surgical bypass. Therefore, patients with repeated upper gastrointestinal bleeding are often admitted and discharged from the hospital, repeatedly, which is a great waste of social resources. Since bleeding cannot be plugged, what should be done? Da Yu’s treatment tells us that if it cannot be plugged, then unblocking is a good option. Transjugular intrahepatic portosystemic stent shunt (TIPSS) by transjugular route, DIPS (Direct intra-hepatic portocaval shunt ) by direct percutaneous transhepatic puncture is to cannulate the intrahepatic portal vein through the jugular vein to the hepatic vein, or directly puncture the intrahepatic portal vein and establish a shunt tract between the intrahepatic portal vein and the inferior vena cava after implanting an expandable metal stent to make The pressure in the entire extrahepatic portal vein system is significantly reduced to treat ruptured gastroesophageal variceal bleeding. Several studies have shown that emergency TIPS is effective in 90-99% of patients with acute bleeding, and the efficiency of preventing recurrent bleeding is 85%-90% in ≤6 months, 70%-85% in ≤1 year, and 45%-70% in ≤2 years. In April 2012, the annual meeting of the European Association for the Study of the Liver (EASL) has reached a consensus that TIPS is the only “rescue therapy” for acute variceal bleeding for which medical and endoscopic treatments are ineffective. Our interventional vascular surgery department, with the cooperation and assistance of hepatobiliary department, gastroenterology department and emergency department, has made great progress. From September 2011 to June 2012, we completed 15 cases of “transjugular intrahepatic portal vein stent shunt”, 6 cases of “portal vein opening and stent implantation”, 7 cases of “splenic embolization “7 cases, 5 cases of “opening and stenting of the inferior vena cava in Buga’s syndrome”, and the complex “transjugular intrahepatic portal vein stent shunt combined with variceal fundic esophageal vein embolization and dissection”. At present, the patients are under post-operative follow-up and are generally in good condition. We have become the only unit in Hunan Province that can routinely perform, independently, a comprehensive procedure of portal vein dissection, shunt and opening under minimally invasive procedures. The development of minimally invasive treatment for portal hypertension in our hospital has brought a boon to patients with upper gastrointestinal bleeding from portal hypertension in Hunan Province, which is extremely well coordinated with all clinical departments of our hospital and provides more options for medical workers in our department.